Our Services
Medical Information
Helpful Resources
Published on: 10/26/2026
Rosuvastatin 20 mg is a moderate-to-high intensity statin dose that typically lowers LDL cholesterol by about 50% or more, yet it also brings a greater chance of muscle aches, weakness, headache, nausea, constipation, and elevated liver enzymes than 5 mg or 10 mg. Rare but serious problems such as myopathy, rhabdomyolysis, kidney strain, and modest increases in blood sugar become somewhat more likely as the dose climbs, particularly in adults over 65, people of Asian ancestry, and those with kidney or thyroid disease or interacting medications. Many people tolerate 20 mg well, and symptoms often ease within a few weeks or respond to a lower dose, alternate-day dosing, or a different statin, so there are several important factors to consider before making any change. See below for the full dose-by-d
Rosuvastatin is a widely prescribed statin medication used to lower LDL (“bad”) cholesterol and reduce cardiovascular risk. The 20 mg dose sits between typical starting doses (5–10 mg) and the highest dose (40 mg). Understanding side effects and how they compare to lower doses can help you and your doctor make the safest, most effective choice.
Most people tolerate rosuvastatin well, but some side effects are more likely at higher doses. Common side effects include:
These side effects affect roughly 5–10 % of people on the 20 mg dose. They often improve after the first month as your body adjusts.
While rare, serious reactions can occur. Seek immediate medical attention for:
Always discuss any troubling symptoms with your healthcare provider. For a free, online symptom check, using the doctor approved Ubie Symptom Checker, click here.
Choosing between 5 mg, 10 mg, and 20 mg depends on your cholesterol levels, risk factors, and tolerance of side effects.
| Dose | LDL Reduction (Approx.) | Common Side Effect Rate | Monitoring Needs |
|---|---|---|---|
| 5 mg | 35 % | 3–5 % | Baseline LFT & CK, then as needed |
| 10 mg | 45 % | 5–7 % | LFT & CK at 8–12 weeks |
| 20 mg | 50 % | 7–10 % | LFT & CK at 6–12 weeks |
Certain factors can increase the chance of side effects on rosuvastatin 20 mg:
If you have any of these, your doctor may start at a lower dose or choose an alternative statin.
If you experience mild side effects on 20 mg, consider:
Always keep an open dialogue with your healthcare provider. Contact them promptly if you experience:
For urgent or life-threatening symptoms, seek emergency care. Otherwise, schedule a routine follow-up to discuss lab tests and dose adjustments.
Rosuvastatin 20 mg offers a potent reduction in LDL cholesterol and cardiovascular risk. But higher efficacy comes with a slightly increased chance of side effects compared to lower doses. Together with your doctor, weigh:
Your doctor can help you find the lowest effective dose that achieves your LDL goals while minimizing side effects.
Before making changes, speak to your doctor to ensure your dose aligns with your health needs.
(References)
* Jones PH, Davidson MH, Stein EA, Bays HE, McKenney JM, Miller E, Cain VA, Blasetto JW, STELLAR Study Group. Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial). Am J Cardiol. 2003 Jul 15;92(2):152-60. doi: 10.1016/s0002-9149(03)00530-7. PMID: 12860216.
* Grundy SM. The issue of statin safety: where do we stand? Circulation. 2005 Jun 14;111(23):3016-9. doi: 10.1161/CIRCULATIONAHA.105.557652. Epub 2005 May 23. PMID: 15911705.
* Vrettos I, Papageorgiou S, Economopoulou C, Pappa V, Tsirigotis P, Tountas N, Economopoulos T, Dervenoulas J. Rosuvastatin-induced thrombocytopenia. South Med J. 2010 Jul;103(7):676-8. doi: 10.1097/SMJ.0b013e3181e170f5. PMID: 20531065.
* Rivera Irigoín R, Nicolau Ramis J, Terrasa Sagrista F, Masmiquel Comas L. [Rosuvastatin-induced erythema multiforme]. Med Clin (Barc). 2013 Jun 4;140(11):523-4. doi: 10.1016/j.medcli.2012.09.035. Epub 2012 Dec 12. PMID: 23245532.
* Brailovski E, Kim RB, Juurlink D. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment. Ann Intern Med. 2021 Mar;174(3):432. doi: 10.7326/L20-1456. PMID: 33721527.
* Mamidi RNVS, Devineni D, Sun D, Yavin Y, Rosenthal N. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment. Ann Intern Med. 2021 Mar;174(3):431-432. doi: 10.7326/L20-1455. PMID: 33721528.
* Alamer A, Te C, Fazel MT. Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment. Ann Intern Med. 2021 Mar;174(3):431. doi: 10.7326/L20-1454. PMID: 33721529.
* Barus R, Jouvray M, Gautier S, Potey C. Rosuvastatin-Induced Dysarthria: An Unusual Drug Reaction. Ann Pharmacother. 2022 Dec;56(12):1382-1383. doi: 10.1177/10600280221085816. Epub 2022 Apr 7. PMID: 35392669.
* Laffin LJ, Bruemmer D, Garcia M, Brennan DM, McErlean E, Jacoby DS, Michos ED, Ridker PM, Wang TY, Watson KE, Hutchinson HG, Nissen SE. Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory Biomarkers. J Am Coll Cardiol. 2023 Jan 3;81(1):1-12. doi: 10.1016/j.jacc.2022.10.013. Epub 2022 Nov 6. PMID: 36351465.
* Zhou S, Chen R, Liu J, Guo Z, Su L, Li Y, Zhang X, Luo F, Gao Q, Lin Y, Pang M, Cao L, Xu X, Nie S. Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin : A Multi-database Cohort Study. Ann Intern Med. 2024 Dec;177(12):1641-1651. doi: 10.7326/M24-0178. Epub 2024 Oct 29. PMID: 39467290.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.